Confirm cancellation
Something went wrong.
An error occurred trying to play the stream. Please reload the page and try again.
CloseSign-up to join the ION Analytics Community to:
- Register for events
- Access market insights
- Download reports
An error occurred trying to play the stream. Please reload the page and try again.
CloseTim Burroughs is managing editor of Asian Venture Capital Journal, having joined the publication in May 2011. He is responsible for all editorial content put out under the AVCJ brand, including Asian Venture Capital Journal, AVCJtv, AVCJ Awards and AVCJ.com. Tim previously spent five years at China Economic Review, serving as editor-in-chief and then editorial director. Located in Greater China since 2003, during which time he has lived in Beijing, Qingdao and Hong Kong, Tim has been a China-based contributor for publications including The Sunday Times, Sunday Telegraph, BBC and China Daily. Prior to moving to China, he trained and worked as a journalist in the UK. He was honored at the Society of Publishers in Asia awards in 2007, 2008 and 2010, and at the State Street Institutional Press Awards - Asia in 2012.
Mr. Fu oversees the firm’s overall strategy, talent development and is responsible for maintaining the firm’s long-term partnerships with global investors. He has driven successful incubation and buyout strategies, shaping the firm’s differentiated investment approach. Under his leadership, CBC Group was recognized by PEI in 2024 as the #1 private equity firm in Singapore and Asia’s largest healthcare-focused firm, earning this title for the third consecutive year, with the Group’s AUM having grown from US$180 million in 2014 to US$10.5 billion today.
He initiated and led investment transactions including Everest Medicines (HKEX 1952.HK), Hugel Inc. (KOSDAQ:145020), ENSEM Therapeutics (Boston, US) and I-Mab Biopharma (NASDAQ: IMAB), while also being instrumental in incubating several biotech and pharmaceutical companies. He serves as Chairman of the Board for Everest Medicines and I-MAB Biopharma respectively.
Prior to founding CBC Group in 2014, he was formerly the General Manager of the investment department at a wholly owned subsidiary of Far East Horizon Limited (HKEX:3360). He has also worked for Standard Chartered Bank (China), Macquarie Capital (Singapore) and Temasek Holdings.
Fu Wei graduated from Singapore’s Nanyang Technological University with a first-class honors degree in Electrical Engineering and a minor in Business Administration. He is a scholar of Singapore's Ministry of Education and a member of the prestigious Young President’s Organization.